Ontario hospital to share patient data with QuadraMed EMR

Jeff Byers | | Health Exec | Informatics
Providence Care, a health services provider based in Kingston, Ontario, has selected QuadraMed’s computerized-patient record (QCPR) EMR to drive regional patient data sharing.

Providence Care will implement QCPR, QuadraMed Enterprise Scheduling (QES) and QuadraMed Electronic Document Management (QEDM) at St. Mary's of the Lake Hospital (144-bed hospital), Mental Health Services (198-bed hospital), Providence Manor (243-bed long-term care home) and 18 community locations across southeastern Ontario.

Providence Care will join with Kingston General Hospital and Hotel Dieu Hospital to create an integrated installation of QuadraMed that will be shared between the three hospitals and provide patient care for the residents of Kingston and the surrounding area, the Reston, Va.-based company stated.

Jeff Byers

Related Content

Alabama security breach exposes personal information of cardiologists, heart patients
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems
Cloud image storage for radiology is a growing trend in healthcare
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.